Smofkabiven Peripheral 63 mg

SMOFKABIVEN Peripheral 63 MG is an intravenous emulsion containing tryptophan, designed for nutritional support. This product is manufactured by Fresenius Kabi Canada Ltd. and is suitable for peripheral administration.

SMOFKABIVEN Peripheral 63 MG is primarily used for nutritional support in patients who cannot consume food orally. It provides essential amino acids, including tryptophan, which are crucial for protein synthesis and overall health. This emulsion is often used in clinical settings to support patients who require intravenous nutrition.

When administered intravenously, SMOFKABIVEN Peripheral 63 MG provides the body with essential amino acids, which are building blocks for proteins. These amino acids help in maintaining and repairing tissues, supporting immune function, and promoting overall health. The emulsion is designed to be well-tolerated when used as directed.

SMOFKABIVEN Peripheral 63 MG should be administered under medical supervision. It is important to follow proper handling and storage guidelines to ensure the emulsion remains stable and effective. Patients with known allergies to any of the components should avoid using this product.

SMOFKABIVEN Peripheral 63 MG may interact with other medications or supplements. It is important to inform healthcare providers about all current medications to avoid potential interactions. Always consult a healthcare professional before starting any new treatment.